cardiovascular research

Waltham, Massachusetts, U.S., September 16, 2026 Skyhawk Therapeutics has announced final 15-month results from its Phase 1/2 clinical trial...

Seattle, Washington, U.S., September 15, 2026 HDT Bio Corp. has received an ARPA-H GIVE award to lead the development...

Toronto, Ontario, Canada, September 16, 2026 Thryv Therapeutics has announced the publication of new research in JACC: Heart Failure...

EVANSTON, Ill., June 2, 2026 Researchers at Endeavor Health have developed a groundbreaking genetic screening tool designed to provide...

ENCINITAS, Calif., May 11, 2026 Vasa Therapeutics, a clinical-stage biotechnology company focused on therapies targeting cardiovascular and metabolic aging,...

MADRID & NEW YORK, January 29, 2026 — A multicenter randomized clinical trial has demonstrated that remote dielectric sensing...